结果:全组5年总生存率(overall survival,OS)和无病生存率(disease-freely survival,DFS)分别是68.0%和55.8%.
基于4个网页-相关网页
purji.com 验以及Meta分析均显示,新辅助化疗和辅助化疗之间在生存率(overall survival,OS)和无病生存率(disease free survival,DFS)以及远处转移上均无明显的差异[1-3],但由于其具备缩小原发灶、提高保乳手术率、观察抗癌药物的敏感程..
基于2个网页-相关网页
...网 ，VEGF表达分成阴性和阳性两组，分别比较各自的总体生存率（overall survival,OS）和无病生存率（disease-freesurvival,DFS）（此处无病生存即指未带瘤生存）。
基于2个网页-相关网页
和无白血病生存率 leukemia-free survival ; LFS
观察两组患者的临床疗效、组织学疗效、对化疗的毒副反应，以及术后3年生存率和无病存活率，并进行对比分析。
The clinical and histological effects, toxic and side reaction of chemotherapy such as nausea and vomit, the 3-year survival rates and disease-free survival rates were analyzed.
柳叶刀上有报道说如果供者的血和病人的匹配很好，那么两种方法的白血病的无病生存率很相近。
If the donor blood was well matched to the patient, the rate of leukemia-free surial was similar in both methods, according to the findings published in The Lancet.
结论MAE方案可提高老年aml的缓解率和长期无病生存率。
Conclusion MAE protocol can improve CR rate in elderly patients of AML.
应用推荐